Media coverage
11
Media coverage
Title Onconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting & Exposition Media name/outlet Plus Company Updates (PCU) Country/Territory United States Date 6/11/18 Persons John Roboz, Shyamala Navada Title Onconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting & Exposition Media name/outlet India Pharma News Country/Territory India Date 5/11/18 Persons John Roboz, Shyamala Navada Title Onconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting & Exposition Media name/outlet Nasdaq Country/Territory United States Date 5/11/18 URL https://www.nasdaq.com/press-release/onconova-announces-four-presentations-from-rigosertib-clinical-trials-in-myelodysplastic-syndromes-20181105-00608 Persons John Roboz, Shyamala Navada Title Onconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting & Exposition Media name/outlet PM 360 Country/Territory United States Date 5/11/18 URL https://www.pm360online.com/onconova-announces-four-presentations-from-rigosertib-clinical-trials-in-myelodysplastic-syndromes-mds-at-the-2018-ash-annual-meeting-exposition/ Persons John Roboz, Shyamala Navada Title Onconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting & Exposition Media name/outlet Stockwatch Country/Territory Canada Date 5/11/18 URL www.stockwatch.com/News/Item.aspx?bid=U-z7423740-U%3aONTX-20181105&symbol=ONTX®ion=U Persons John Roboz, Shyamala Navada Title Onconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting & Exposition Media name/outlet Spoke.com Country/Territory United States Date 5/11/18 URL www.spoke.com/press_releases/5be04d352cf3f7f6cb032e1b Persons John Roboz, Shyamala Navada Title Onconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting & Exposition Media name/outlet Cafepharma.com Country/Territory United States Date 5/11/18 URL www.cafepharma.com/nasdaq_news/1525858 Persons John Roboz, Shyamala Navada Title Onconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting & Exposition Media name/outlet PrimeNewswire (Top News) Country/Territory United States Date 5/11/18 Persons John Roboz, Shyamala Navada Title Onconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting & Exposition Media name/outlet PrimeNewswire (XML) Country/Territory United States Date 5/11/18 Persons John Roboz, Shyamala Navada Title Onconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting & Exposition Media name/outlet GlobeNewswire Country/Territory United States Date 5/11/18 URL globenewswire.com/news-release/2018/11/05/1645084/0/en/Onconova-Announces-Four-Presentations-from-Rigosertib-Clinical-Trials-in-Myelodysplastic-Syndromes-MDS-at-the-2018-ASH-Annual-Meeting-Exposition.html Persons John Roboz, Shyamala Navada Title Onconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual ... Media name/outlet EIN News Country/Territory United States Date 5/11/18 URL https://www.einpresswire.com/article/467228545/onconova-announces-four-presentations-from-rigosertib-clinical-trials-in-myelodysplastic-syndromes-mds-at-the-2018-ash-annual-meeting-exposition Persons John Roboz, Shyamala Navada